Amgen IncAMGN:NSQ

156.67
0.68 / 0.43%
1.56m
35.06%
0.4906
Real-time price in USDToday's changeShares traded1 year changeBeta
As of May 29 2015 17:09 BST. BATS BZX Real-Time Last Sale

Summary

As of last trade Amgen Inc (AMGN:NSQ) traded at 156.67, 9.75 % below its 52-week high of 173.60, set on Apr 22, 2015.

52-week range
Today
114.93
Jul 18 2014
173.60
Apr 22 2015
Markit short selling activity
Low
Medium
High
Open156.79
Day high157.97
Day low156.14
Bid156.55
Offer156.80
Previous close157.35
Average volume2.67m
Shares outstanding760.32m
Free float759.12m
P/E (TTM)21.23
Market cap119.64bn USD
EPS (TTM)7.41 USD
Annual div (IAD)3.16 USD
Annual div yield (IAD)1.97%
Div ex-dateMay 12 2015
Div pay-dateJun 05 2015
As of May 29 2015 17:09 BST.BATS BZX Real-Time Quote

Comparative analysis

Past 90 days
1 week1 month6 months1 year5 years
Amgen Inc-4.46 %-2.91 %-5.46 %+34.73 %+201.83 %
S&P 500 INDEX-0.25 %+0.66 %+2.57 %+10.46 %+94.67 %
USA/HEALTH CARE+0.23 %+3.11 %+8.03 %+21.48 %+62.45 %
USA/BIOTECHNOLOGY-0.65 %+3.97 %+8.96 %+29.20 %+79.31 %
Data delayed at least 15 minutes, as of May 29 2015 16:55 BST.
© Thomson Reuters Click for restrictions.

Real-time data provided by BATS.

All markets data located on FT.com is subject to the FT Terms & Conditions.

All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.

Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.

Markit Short Selling Activity © Markit. All rights reserved.
Although Markit has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of Markit on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.